Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005-2020.

Autor:	Morishita F; End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Elsayed H; End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Islam T; End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Rahevar K; End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Oh KH; End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Yanagawa M; End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Floyd K; Global TB Programme, World Health Organization, Geneva, Switzerland., Baena IG; Global TB Programme, World Health Organization, Geneva, Switzerland.
Jazyk:	angličtina
Zdroj:	Western Pacific surveillance and response journal : WPSAR [Western Pac Surveill Response J] 2023 Aug 18; Vol. 14 (3), pp. 1-13. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2023).
DOI:	10.5365/wpsar.2023.14.3.976
Abstrakt:	Objective: This paper provides an overview of financing for tuberculosis (TB) prevention, diagnostic and treatment services in the World Health Organization (WHO) Western Pacific Region during 2005-2020. Methods: This analysis uses the WHO global TB finance database to describe TB funding during 2005-2020 in 18 low- and middle-income countries (LMICs) in the Western Pacific Region, with additional country-level data and analysis for seven priority countries: Cambodia, China, the Lao People's Democratic Republic, Mongolia, Papua New Guinea, the Philippines and Viet Nam. Results: Funding for the provision of TB prevention, diagnostic and treatment services in the 18 LMICs tripled fromUS$ 358 million in 2005 to US$ 1061 million in 2020, driven largely by increases in domestic funding, which rose from US$ 325 million to US$ 939 million over the same period. In the seven priority countries, TB investments also tripled, from US$ 340 million in 2005 to US$ 1020 million in 2020. China alone accounted for much of this growth, increasing its financing for TB programmes and services fivefold, from US$ 160 million to US$ 784 million. The latest country forecasts estimate that US$ 3.8 billion will be required to fight TB in the seven priority countries by 2025, which means that unless additional funding is mobilized, the funding gap will increase from US$ 326 million in 2020 to US$ 830 million by 2025. Discussion: Increases in domestic funding over the past 15 years reflect a firm political commitment to ending TB. However, current funding levels do not meet the required needs to finance the national TB strategic plans in the priority countries. An urgent step-up of public financing efforts is required to reduce the burden of TB in the Western Pacific Region. Competing Interests: The authors have no conflicts of interest to declare. ((c) 2023 The authors; licensee World Health Organization.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu